Clinical trials
Terminated Carcinoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott | 1 |
| Amgen | 1 |
| Association of Urologic Oncology (AUO) | 1 |
| Daiichi Sankyo | 1 |
| German Cancer Research Center | 1 |
| Hoffmann-La Roche | 1 |
| Novartis Pharmaceuticals | 1 |
| Symphogen A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 8 |
| Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Adenocarcinoma | 3 |
| Neoplasms by Histologic Type | 3 |
| Neoplasms by Site | 3 |
| Colorectal Neoplasms | 2 |
| Lung Diseases | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.